183 related articles for article (PubMed ID: 25319102)
1. Reduction-responsive crosslinked micellar nanoassemblies for tumor-targeted drug delivery.
Fan W; Wang Y; Dai X; Shi L; Mckinley D; Tan C
Pharm Res; 2015 Apr; 32(4):1325-40. PubMed ID: 25319102
[TBL] [Abstract][Full Text] [Related]
2. Combined Delivery of Let-7b MicroRNA and Paclitaxel via Biodegradable Nanoassemblies for the Treatment of KRAS Mutant Cancer.
Dai X; Fan W; Wang Y; Huang L; Jiang Y; Shi L; Mckinley D; Tan W; Tan C
Mol Pharm; 2016 Feb; 13(2):520-33. PubMed ID: 26636714
[TBL] [Abstract][Full Text] [Related]
3. Core-crosslinked pH-sensitive degradable micelles: A promising approach to resolve the extracellular stability versus intracellular drug release dilemma.
Wu Y; Chen W; Meng F; Wang Z; Cheng R; Deng C; Liu H; Zhong Z
J Control Release; 2012 Dec; 164(3):338-45. PubMed ID: 22800578
[TBL] [Abstract][Full Text] [Related]
4. Well-defined, reversible disulfide cross-linked micelles for on-demand paclitaxel delivery.
Li Y; Xiao K; Luo J; Xiao W; Lee JS; Gonik AM; Kato J; Dong TA; Lam KS
Biomaterials; 2011 Sep; 32(27):6633-45. PubMed ID: 21658763
[TBL] [Abstract][Full Text] [Related]
5. Facile construction of bioreducible crosslinked polypeptide micelles for enhanced cancer combination therapy.
Ruttala HB; Chitrapriya N; Kaliraj K; Ramasamy T; Shin WH; Jeong JH; Kim JR; Ku SK; Choi HG; Yong CS; Kim JO
Acta Biomater; 2017 Nov; 63():135-149. PubMed ID: 28890258
[TBL] [Abstract][Full Text] [Related]
6. Galactose-installed photo-crosslinked pH-sensitive degradable micelles for active targeting chemotherapy of hepatocellular carcinoma in mice.
Zou Y; Song Y; Yang W; Meng F; Liu H; Zhong Z
J Control Release; 2014 Nov; 193():154-61. PubMed ID: 24852094
[TBL] [Abstract][Full Text] [Related]
7. Fmoc-conjugated PEG-vitamin E2 micelles for tumor-targeted delivery of paclitaxel: enhanced drug-carrier interaction and loading capacity.
Zhang Y; Huang Y; Zhao W; Lu J; Zhang P; Zhang X; Li J; Gao X; Venkataramanan R; Li S
AAPS J; 2014 Nov; 16(6):1282-91. PubMed ID: 25193267
[TBL] [Abstract][Full Text] [Related]
8. Poly(ethylene glycol)-block-poly(ε-caprolactone) micelles for combination drug delivery: evaluation of paclitaxel, cyclopamine and gossypol in intraperitoneal xenograft models of ovarian cancer.
Cho H; Lai TC; Kwon GS
J Control Release; 2013 Feb; 166(1):1-9. PubMed ID: 23246471
[TBL] [Abstract][Full Text] [Related]
9. Free paclitaxel loaded PEGylated-paclitaxel nanoparticles: preparation and comparison with other paclitaxel systems in vitro and in vivo.
Lu J; Chuan X; Zhang H; Dai W; Wang X; Wang X; Zhang Q
Int J Pharm; 2014 Aug; 471(1-2):525-35. PubMed ID: 24858391
[TBL] [Abstract][Full Text] [Related]
10. A novel size-tunable nanocarrier system for targeted anticancer drug delivery.
Li Y; Xiao K; Luo J; Lee J; Pan S; Lam KS
J Control Release; 2010 Jun; 144(3):314-23. PubMed ID: 20211210
[TBL] [Abstract][Full Text] [Related]
11. Dual drug-loaded polymeric mixed micelles for ovarian cancer: Approach to enhanced therapeutic efficacy of albendazole and paclitaxel.
Gaikwad NM; Chaudhari PD; Shaikh KS; Chaudhari SY; Pathare SS; Shaikh AA; Aljarba NH; Kumer A; Dhara B
J Cell Mol Med; 2024 Jun; 28(11):e18389. PubMed ID: 38864691
[TBL] [Abstract][Full Text] [Related]
12. Complete Regression of Xenograft Tumors upon Targeted Delivery of Paclitaxel via Π-Π Stacking Stabilized Polymeric Micelles.
Shi Y; van der Meel R; Theek B; Oude Blenke E; Pieters EH; Fens MH; Ehling J; Schiffelers RM; Storm G; van Nostrum CF; Lammers T; Hennink WE
ACS Nano; 2015; 9(4):3740-52. PubMed ID: 25831471
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and evaluation of a paclitaxel-binding polymeric micelle for efficient breast cancer therapy.
Xiang J; Wu B; Zhou Z; Hu S; Piao Y; Zhou Q; Wang G; Tang J; Liu X; Shen Y
Sci China Life Sci; 2018 Apr; 61(4):436-447. PubMed ID: 29572777
[TBL] [Abstract][Full Text] [Related]
14. Targeted glioma chemotherapy by cyclic RGD peptide-functionalized reversibly core-crosslinked multifunctional poly(ethylene glycol)-b-poly(ε-caprolactone) micelles.
Fang Y; Jiang Y; Zou Y; Meng F; Zhang J; Deng C; Sun H; Zhong Z
Acta Biomater; 2017 Mar; 50():396-406. PubMed ID: 28065871
[TBL] [Abstract][Full Text] [Related]
15. Co-delivery of paclitaxel and cisplatin in poly(2-oxazoline) polymeric micelles: Implications for drug loading, release, pharmacokinetics and outcome of ovarian and breast cancer treatments.
Wan X; Beaudoin JJ; Vinod N; Min Y; Makita N; Bludau H; Jordan R; Wang A; Sokolsky M; Kabanov AV
Biomaterials; 2019 Feb; 192():1-14. PubMed ID: 30415101
[TBL] [Abstract][Full Text] [Related]
16. Dual thermoresponsive and pH-responsive self-assembled micellar nanogel for anticancer drug delivery.
Chen D; Yu H; Sun K; Liu W; Wang H
Drug Deliv; 2014 Jun; 21(4):258-64. PubMed ID: 24102086
[TBL] [Abstract][Full Text] [Related]
17. Reduction-sensitive dual functional nanomicelles for improved delivery of paclitaxel.
Zhang X; Liu K; Huang Y; Xu J; Li J; Ma X; Li S
Bioconjug Chem; 2014 Sep; 25(9):1689-96. PubMed ID: 25121577
[TBL] [Abstract][Full Text] [Related]
18. Extremely long tumor retention, multi-responsive boronate crosslinked micelles with superior therapeutic efficacy for ovarian cancer.
Xiao W; Suby N; Xiao K; Lin TY; Al Awwad N; Lam KS; Li Y
J Control Release; 2017 Oct; 264():169-179. PubMed ID: 28847739
[TBL] [Abstract][Full Text] [Related]
19. Poly(ethylene glycol) crosslinked multi-armed poly(ε-benzyloxycarbonyl-L-lysine)s as super-amphiphiles: Synthesis, self-assembly, and evaluation as efficient delivery systems for poorly water-soluble drugs.
Lu C; Jiang L; Xu W; Yu F; Xia W; Pan M; Zhou W; Pan X; Wu C; Liu D
Colloids Surf B Biointerfaces; 2019 Oct; 182():110384. PubMed ID: 31357126
[TBL] [Abstract][Full Text] [Related]
20. Biodegradable hybrid polymer micelles for combination drug therapy in ovarian cancer.
Desale SS; Cohen SM; Zhao Y; Kabanov AV; Bronich TK
J Control Release; 2013 Nov; 171(3):339-48. PubMed ID: 23665258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
